全球水产养殖疫苗市场研究报告-行业分析、规模、份额、增长、趋势及2023年至2030年预测

预计到2030年，全球水产养殖疫苗市场需求将从2022年的4.2707亿美元达到近9.4244亿美元，2023-2030年复合年增长率为10.4%。

水产养殖疫苗是专门设计用于水产养殖（养殖鱼类、贝类和甲壳类等水生生物）的疫苗。这些疫苗有助于保护养殖的水生生物免受疾病的侵害，这些疾病会降低其健康状况、生长速度和总体产量。

市场动态：

全球对海产品的需求不断增长，推动了水产养殖业的发展，同时也带动了对水产养殖疫苗的需求。随着该行业的扩大，保护养殖物种健康的需求也随之增加。水产养殖场疾病爆发频率的增加突出了对有效疫苗接种计划的需求。这些疾病的爆发会给养殖户带来巨大的经济损失，并影响养殖物种的健康，进而影响最终产品的质量。疫苗技术的进步导致开发出更有效、更安全的疫苗用于水产养殖。疫苗在水产养殖中的使用已变得越来越普遍，新疫苗也在不断开发，以预防新的和新出现的疾病。世界各国政府都在为水产养殖业提供支持，包括对疫苗研发的投资。这导致了新疫苗的开发和现有疫苗计划的扩大。随着人们对水产养殖中疫苗接种益处的认识不断提高，预计对水产养殖疫苗的需求将继续增加。在水产养殖业迅速发展的发展中国家尤其如此。

研究报告包括波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰了解行业结构，评估全球竞争吸引力。此外，这些工具还对全球水产养殖疫苗市场的各个细分市场进行了全面评估。水产养殖疫苗行业的增长和趋势为本研究提供了整体方法。

市场细分：

水产养殖疫苗市场报告的这一部分提供了国家和地区层面细分市场的详细数据，从而帮助战略家确定各自产品或服务的目标人群以及即将到来的机会。

按产品分类

• 减毒活疫苗
• 灭活疫苗
• 亚单位疫苗
• DNA疫苗
• 重组疫苗

按给药途径

• 口服
• 注射剂
• 浸泡和喷雾

按应用

• 细菌
• 病毒
• 寄生虫

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太、拉美以及中东和非洲地区水产养殖疫苗市场的当前和未来需求。此外，报告还重点介绍了所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的综合概况以及全球竞争格局的深入分析。水产养殖疫苗市场的主要参与者包括Zoetis、Phibro Animal Health Corporation、Elanco、Merck & Co.Inc.、KBNP、Cavac、Kyoto Biken Laboratories Inc.、Nisseiken Co.Ltd.、Vaxxinova International BV、Hipra。本部分包括竞争格局的整体观点，其中包括各种战略发展，如关键并购、未来能力、合作伙伴关系、财务概况、合作、新产品开发、新产品上市和其他发展。

目 录

第一章：前言

• 报告描述
  • 报告目标
  • 目标受众
  • 独特销售主张（USP）和产品
• 研究范围
• 研究方法
  • 市场调研流程
  • 市场调研方法

第二章：执行摘要

• 市场亮点
• 全球市场概况

第三章：水产养殖疫苗-行业分析

• 简介 - 市场动态
• 市场驱动因素
• 市场限制因素
• 市场机会
• 行业趋势
• 波特五力分析
• 市场吸引力分析
  • 按产品分类的市场吸引力分析
  • 按给药途径的市场吸引力分析
  • 市场吸引力分析：按应用
  • 市场吸引力分析：按地区

第四章：价值链分析

• 价值链分析
• 原材料分析
  • 原材料清单
  • 原材料制造商列表
  • 主要原材料价格走势
• 潜在买家名单
• 营销渠道
  • 直接营销
  • 间接营销
  • 营销渠道发展趋势

第五章：COVID-19爆发的影响分析

第六章：全球水产养殖疫苗市场分析：按产品分类

• 产品概述
• 历史和预测数据
• 产品分析
• 减毒活疫苗
• 灭活疫苗
• 亚单位疫苗
• DNA疫苗
• 重组疫苗

第七章 ：全球水产养殖疫苗市场分析：按给药途径分类

• 给药途径概述
• 历史和预测数据
• 按给药途径分析
• 口服
• 注射
• 浸泡和喷雾

第八章 : 全球水产养殖疫苗市场销售分析：按应用分类

• 概述：按应用
• 历史和预测数据
• 分析：按应用
• 细菌
• 病毒
• 寄生虫

第九章 : 全球水产养殖疫苗市场销售分析：按地域划分

• 区域展望 销售分析
• 销售分析
• 北美销售分析
  • 概述、历史和预测销售分析
  • 北美细分市场销售分析
  • 北美各国销售分析
  • 美国销售分析
  • 加拿大销售分析
  • 墨西哥销售分析
• 欧洲销售分析
  • 概述、历史和预测销售分析
  • 欧洲销售分析
  • 欧洲各国销售分析
  • 英国销售分析
  • 法国销售分析
  • 德国销售分析
  • 意大利销售分析
  • 俄罗斯销售分析
  • 欧洲其他地区销售分析
• 亚太地区销售分析
  • 概述、历史和预测销售分析
  • 亚太地区各细分市场销售分析
  • 亚太地区各国销售分析
  • 中国销售分析
  • 印度销售分析
  • 日本销售分析
  • 韩国销售分析
  • 澳大利亚销售分析
  • 亚太其他地区销售分析
• 拉丁美洲销售分析
  • 概述、历史和预测销售分析
  • 拉丁美洲各细分市场销售分析
  • 拉丁美洲各国销售分析
  • 巴西销售分析
  • 阿根廷销售分析
  • 秘鲁销售分析
  • 智利销售分析
  • 拉丁美洲其他地区销售分析
• 中东和非洲销售分析
  • 概述、历史和预测销售分析
  • 中东和非洲各细分市场销售分析
  • 中东和非洲国家销售分析
  • 沙特阿拉伯销售分析
  • 阿联酋销售分析
  • 以色列销售分析
  • 南非销售分析
  • 中东和非洲其他地区销售分析

第十章 : 水产养殖疫苗企业竞争格局

• 水产养殖疫苗市场竞争
• 伙伴关系/合作/协议
• 合併与收购
• 新产品上市
• 其他发展

第十一章 ：公司概况

• 前10强企业份额分析
• 市场集中率
• Zoetis
  • 公司概况
  • 公司收入
  • 产品
  • 近期发展
• Phibro Animal Health Corporation
  • 公司概况
  • 公司收入
  • 产品
  • 近期发展
• Elanco
  • 公司概况
  • 公司收入
  • 产品
  • 近期发展
• Merck & Co. Inc.
  • 公司概况
  • 公司收入
  • 产品
  • 近期发展
• KBNP
  • 公司概况
  • 公司收入
  • 产品
  • 近期发展
• Cavac
  • 公司概况
  • 公司收入
  • 产品
  • 近期发展
• Kyoto Biken Laboratories Inc.
  • 公司概况
  • 公司收入
  • 产品
  • 近期发展
• Nisseiken Co. Ltd.
  • 公司概况
  • 公司收入
  • 产品
  • 近期发展
• Vaxxinova International BV
  • 公司概况
  • 公司收入
  • 产品
  • 近期发展
• Hipra
  • 公司概况
  • 公司收入
  • 产品
  • 近期发展

*注：在公司概况中，财务细节和近期发展取决于可用性，如果是私营公司，则可能不包括在内。

The global demand for Aquaculture Vaccines Market is presumed to reach the market size of nearly USD 942.44 MN by 2030 from USD 427.07 MN in 2022 with a CAGR of 10.4% under the study period 2023 - 2030.

Aquaculture vaccines are vaccines specifically designed for use in aquaculture, the farming of aquatic organisms such as fish, shellfish, and crustaceans. These vaccines help protect farmed aquatic species from diseases and illnesses that can reduce their health, growth, and overall production. 

Market Dynamics:

The increasing demand for seafood worldwide is driving the growth of the aquaculture industry and, with it, the demand for aquaculture vaccines. As the industry expands, the need to protect the health of the farmed species increases. The increased frequency of disease outbreaks in aquaculture farms has highlighted the need for effective vaccination programs. These outbreaks can result in significant financial losses for farmers and can affect the health of the farmed species, which in turn can impact the quality of the final product. Advances in vaccine technology have led to the development of more effective and safe vaccines for use in aquaculture. The use of vaccines in aquaculture has become increasingly common, and new vaccines are constantly being developed to protect against new and emerging diseases. Governments around the world are providing support for the aquaculture industry, including investment in the research and development of vaccines. This is leading to the development of new vaccines and the expansion of existing vaccine programs. As awareness of the benefits of vaccination in aquaculture grows, the demand for aquaculture vaccines is expected to continue to increase. This is particularly true in developing countries, where the aquaculture industry is expanding rapidly.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of aquaculture vaccines. The growth and trends of aquaculture vaccines industry provide a holistic approach to this study. 

Market Segmentation:

This section of the aquaculture vaccines market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities. 

By Product

• Attenuated Live Vaccines
• Inactivated Vaccines
• Subunit Vaccines
• DNA Vaccines
• Recombinant Vaccines

By Route Of Administration

• Oral
• Injected
• Immersion & Spray

By Application

• Bacterial
• Viral
• Parasitic

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Aquaculture Vaccines market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the aquaculture vaccines market include Zoetis, Phibro Animal Health Corporation, Elanco, Merck & Co. Inc., KBNP, Cavac, Kyoto Biken Laboratories Inc., Nisseiken Co. Ltd., Vaxxinova International BV, Hipra. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . AQUACULTURE VACCINES - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product
  • 3.7.2 Market Attractiveness Analysis By Route Of Administration
  • 3.7.3 Market Attractiveness Analysis By Application
  • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL AQUACULTURE VACCINES MARKET ANALYSIS BY PRODUCT

• 6.1 Overview by Product
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Product
• 6.4 Attenuated Live Vaccines Historic and Forecast Sales by Regions
• 6.5 Inactivated Vaccines Historic and Forecast Sales by Regions
• 6.6 Subunit Vaccines Historic and Forecast Sales by Regions
• 6.7 DNA Vaccines Historic and Forecast Sales by Regions
• 6.8 Recombinant Vaccines Historic and Forecast Sales by Regions

7 . GLOBAL AQUACULTURE VACCINES MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

• 7.1 Overview by Route Of Administration
• 7.2 Historical and Forecast Data
• 7.3 Analysis by Route Of Administration
• 7.4 Oral Historic and Forecast Sales by Regions
• 7.5 Injected Historic and Forecast Sales by Regions
• 7.6 Immersion & Spray Historic and Forecast Sales by Regions

8 . GLOBAL AQUACULTURE VACCINES MARKET SALES ANALYSIS BY APPLICATION

• 8.1 Overview by Application
• 8.2 Historical and Forecast Data
• 8.3 Analysis by Application
• 8.4 Bacterial Historic and Forecast Sales by Regions
• 8.5 Viral Historic and Forecast Sales by Regions
• 8.6 Parasitic Historic and Forecast Sales by Regions

9 . GLOBAL AQUACULTURE VACCINES MARKET SALES ANALYSIS BY GEOGRAPHY

• 9.1. Regional Outlook Sales Analysis
• 9.2. Introduction Sales Analysis
• 9.3. North America Sales Analysis
  • 9.3.1. Overview, Historic and Forecast Sales Analysis
  • 9.3.2. North America By Segment Sales Analysis
  • 9.3.3. North America By Country Sales Analysis
  • 9.3.4. United State Sales Analysis
  • 9.3.5. Canada Sales Analysis
  • 9.3.6. Mexico Sales Analysis
• 9.4. Europe Sales Analysis
  • 9.4.1. Overview, Historic and Forecast Sales Analysis
  • 9.4.2. Europe by Segment Sales Analysis
  • 9.4.3. Europe by Country Sales Analysis
  • 9.4.4. United Kingdom Sales Analysis
  • 9.4.5. France Sales Analysis
  • 9.4.6. Germany Sales Analysis
  • 9.4.7. Italy Sales Analysis
  • 9.4.8. Russia Sales Analysis
  • 9.4.9. Rest Of Europe Sales Analysis
• 9.5. Asia Pacific Sales Analysis
  • 9.5.1. Overview, Historic and Forecast Sales Analysis
  • 9.5.2. Asia Pacific by Segment Sales Analysis
  • 9.5.3. Asia Pacific by Country Sales Analysis
  • 9.5.4. China Sales Analysis
  • 9.5.5. India Sales Analysis
  • 9.5.6. Japan Sales Analysis
  • 9.5.7. South Korea Sales Analysis
  • 9.5.8. Australia Sales Analysis
  • 9.5.9. Rest Of Asia Pacific Sales Analysis
• 9.6. Latin America Sales Analysis
  • 9.6.1. Overview, Historic and Forecast Sales Analysis
  • 9.6.2. Latin America by Segment Sales Analysis
  • 9.6.3. Latin America by Country Sales Analysis
  • 9.6.4. Brazil Sales Analysis
  • 9.6.5. Argentina Sales Analysis
  • 9.6.6. Peru Sales Analysis
  • 9.6.7. Chile Sales Analysis
  • 9.6.8. Rest of Latin America Sales Analysis
• 9.7. Middle East & Africa Sales Analysis
  • 9.7.1. Overview, Historic and Forecast Sales Analysis
  • 9.7.2. Middle East & Africa by Segment Sales Analysis
  • 9.7.3. Middle East & Africa by Country Sales Analysis
  • 9.7.4. Saudi Arabia Sales Analysis
  • 9.7.5. UAE Sales Analysis
  • 9.7.6. Israel Sales Analysis
  • 9.7.7. South Africa Sales Analysis
  • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE AQUACULTURE VACCINES COMPANIES

• 10.1. Aquaculture Vaccines Market Competition
• 10.2. Partnership/Collaboration/Agreement
• 10.3. Merger And Acquisitions
• 10.4. New Product Launch
• 10.5. Other Developments

11 . COMPANY PROFILES OF AQUACULTURE VACCINES INDUSTRY

• 11.1. Top 10  Company Share Analysis
• 11.2. Market Concentration Rate
• 11.3. Zoetis
  • 11.3.1. Company Overview
  • 11.3.2. Company Revenue
  • 11.3.3. Products
  • 11.3.4. Recent Developments
• 11.4. Phibro Animal Health Corporation
  • 11.4.1. Company Overview
  • 11.4.2. Company Revenue
  • 11.4.3. Products
  • 11.4.4. Recent Developments
• 11.5. Elanco
  • 11.5.1. Company Overview
  • 11.5.2. Company Revenue
  • 11.5.3. Products
  • 11.5.4. Recent Developments
• 11.6. Merck & Co. Inc.
  • 11.6.1. Company Overview
  • 11.6.2. Company Revenue
  • 11.6.3. Products
  • 11.6.4. Recent Developments
• 11.7. KBNP
  • 11.7.1. Company Overview
  • 11.7.2. Company Revenue
  • 11.7.3. Products
  • 11.7.4. Recent Developments
• 11.8. Cavac
  • 11.8.1. Company Overview
  • 11.8.2. Company Revenue
  • 11.8.3. Products
  • 11.8.4. Recent Developments
• 11.9. Kyoto Biken Laboratories Inc.
  • 11.9.1. Company Overview
  • 11.9.2. Company Revenue
  • 11.9.3. Products
  • 11.9.4. Recent Developments
• 11.10. Nisseiken Co. Ltd.
  • 11.10.1. Company Overview
  • 11.10.2. Company Revenue
  • 11.10.3. Products
  • 11.10.4. Recent Developments
• 11.11. Vaxxinova International BV
  • 11.11.1. Company Overview
  • 11.11.2. Company Revenue
  • 11.11.3. Products
  • 11.11.4. Recent Developments
• 11.12. Hipra
  • 11.12.1. Company Overview
  • 11.12.2. Company Revenue
  • 11.12.3. Products
  • 11.12.4. Recent Developments

 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

•  Market Snapshot
•  Drivers : Impact Analysis
•  Restraints : Impact Analysis
•  List of Raw Material
•  List of Raw Material Manufactures
•  List of Potential Buyers
•  Analysis by Product (USD MN)
•  Attenuated Live Vaccines Market Sales by Geography (USD MN)
•  Inactivated Vaccines Market Sales by Geography (USD MN)
•  Subunit Vaccines Market Sales by Geography (USD MN)
•  DNA Vaccines Market Sales by Geography (USD MN)
•  Recombinant Vaccines Market Sales by Geography (USD MN)
•  Analysis Market by Route Of Administration (USD MN)
•  Oral Market Sales by Geography (USD MN)
•  Injected Market Sales by Geography (USD MN)
•  Immersion & Spray Market Sales by Geography (USD MN)
•  Analysis by Application (USD MN)
•  Bacterial Market Sales by Geography (USD MN)
•  Viral Market Sales by Geography (USD MN)
•  Parasitic Market Sales by Geography (USD MN)
•  Global Aquaculture Vaccines Market Sales by Geography (USD MN)
•  North America Market Analysis (USD MN)
•  United State Market Analysis (USD MN)
•  Canada Market Analysis (USD MN)
•  Mexico Market Analysis (USD MN)
•  Europe Market Analysis (USD MN)
•  Europe Market Estimate by Country (USD MN)
•  United Kingdom Market Analysis (USD MN)
•  France Market Analysis (USD MN)
•  Germany Market Analysis (USD MN)
•  Italy Market Analysis (USD MN)
•  Russia Market Analysis (USD MN)
•  Spain Market Analysis (USD MN)
•  Rest of Europe Market Analysis (USD MN)
•  Asia Pacific Market Analysis (USD MN)
•  China Market Analysis (USD MN)
•  Japan Market Analysis (USD MN)
•  India Market Analysis (USD MN)
•  South Korea Market Analysis (USD MN)
•  Australia Market Analysis (USD MN)
•  Rest of Asia Pacific Market Analysis (USD MN)
•  Latin America Market Analysis (USD MN)
•  Brazil Market Analysis (USD MN)
•  Argentina Market Analysis (USD MN)
•  Peru Market Analysis (USD MN)
•  Chile Market Analysis (USD MN)
•  Rest of Latin America Market Analysis (USD MN)
•  Middle East & Africa Market Analysis (USD MN)
•  Saudi Arabia Market Analysis (USD MN)
•  UAE Market Analysis (USD MN)
•  Israel Market Analysis (USD MN)
•  South Africa Market Analysis (USD MN)
•  Rest of Middle East and Africa Market Analysis (USD MN)
•  Partnership/Collaboration/Agreement
•  Mergers And Acquisition

LIST OF FIGURES

•  Research Scope of Aquaculture Vaccines Report
•  Market Research Process
•  Market Research Methodology
•  Global Aquaculture Vaccines Market Size, by Region (USD MN)
•  Porters Five Forces Analysis
•  Market Attractiveness Analysis by Product
•  Market Attractiveness Analysis by Route Of Administration
•  Market Attractiveness Analysis by Application
•  Market Attractiveness Analysis by Region
•  Value Chain Analysis
•  Global Market Analysis by Product (USD MN)
•  Attenuated Live Vaccines Market Sales by Geography (USD MN)
•  Inactivated Vaccines Market Sales by Geography (USD MN)
•  Subunit Vaccines Market Sales by Geography (USD MN)
•  DNA Vaccines Market Sales by Geography (USD MN)
•  Recombinant Vaccines Market Sales by Geography (USD MN)
•  Global Market Analysis by Route Of Administration (USD MN)
•  Oral Market Sales by Geography (USD MN)
•  Injected Market Sales by Geography (USD MN)
•  Immersion & Spray Market Sales by Geography (USD MN)
•  Global Market Analysis by Application (USD MN)
•  Bacterial Market Sales by Geography (USD MN)
•  Viral Market Sales by Geography (USD MN)
•  Parasitic Market Sales by Geography (USD MN)
•  Global Market by Revenue
•  North America Market by Revenue
•  Europe Market by Revenue
•  Asia Pacific Market by Revenue
•  Latin America Market by Revenue
•  Middle East & Africa Market by Revenue
•  Recent Development in Industry
•  Top Company Share Analysis

 * Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.